• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.29% Nasdaq Down 0.05%

    Curis, Inc. (CRIS)

    -NasdaqGM
    2.57 Down 0.13(4.81%) 1:15PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.70
    Open:2.69
    Bid:2.57 x 100
    Ask:2.58 x 100
    1y Target Est:6.00
    Beta:1.91582
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:2.56 - 2.73
    52wk Range:1.09 - 3.75
    Volume:83,784
    Avg Vol (3m):867,568
    Market Cap:333.11M
    P/E (ttm):N/A
    EPS (ttm):-0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CRISDown 4.81%333.11M
    EXELDown 4.41%1.27B
    PFEDown 0.09%196.99B
    INFIDown 5.57%418.51M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):46.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.52
    Quarterly EPS Est (Sep-15) :-0.08
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback